How to Prepare for Starting Total Parenteral Nutrition

August 25, 2025

Understanding the Foundations of Total Parenteral Nutrition (TPN) Preparation

Starting TPN involves a thorough preparatory process that ensures patient safety, nutritional adequacy, and management of potential risks. This comprehensive guide explores the critical steps, assessment protocols, formulation design, safety measures, and monitoring strategies essential for effective TPN initiation.

Indications and Preconditions for Starting TPN

What are the indications and preconditions for starting total parenteral nutrition (TPN)?

Total parenteral nutrition (TPN) is a vital intervention for patients who cannot meet their nutritional requirements through the usual oral or enteral (tube feeding) routes. It is primarily indicated when gastrointestinal (GI) function is severely impaired or when other routes are contraindicated.

Common conditions that necessitate TPN include bowel obstruction, bowel pseudo-obstruction, GI fistulas with high output, and cases where the GI system is immature or malformed—such as in infants with congenital malformations. TPN is also essential in severe trauma, hypercatabolic states like sepsis, extensive burns, or after major surgeries where the digestive system needs to rest.

In situations where enteral nutrition cannot adequately meet the patient's metabolic needs—especially if the patient is malnourished or expected to be NPO (nothing by mouth) for more than seven days—TPN becomes a crucial alternative. It provides essential nutrients including proteins, carbohydrates, fats, vitamins, minerals, and trace elements directly into the bloodstream.

Initiation of TPN involves careful assessment of the patient’s nutritional status, gastrointestinal function, and overall clinical condition. It is contraindicated if the GI tract is functional and can provide sufficient nutrients, or if the patient’s condition is critically unstable without immediate therapeutic goals. Additionally, patients with good nutritional status and a short expected NPO duration (less than 7 days) may be managed without TPN initially.

Before starting TPN, healthcare providers must evaluate laboratory parameters such as electrolyte levels, liver and kidney function, and overall metabolic profile. Continuous monitoring during therapy is crucial to prevent complications like electrolyte imbalances, infections, or liver toxicity.

In summary, TPN is indicated in cases where the GI tract cannot be used effectively, the patient is malnourished or at risk of malnutrition, and when the anticipated support duration exceeds one week. Proper assessment and close monitoring are essential preconditions to ensure safe and effective nutritional therapy.

Pre-TPN Patient Assessment and Preparation

How should patients be assessed and prepared before starting TPN?

Prior to initiating Total Parenteral Nutrition (TPN), a thorough patient assessment is essential to ensure safety and effectiveness. This process begins with evaluating the patient’s overall nutritional status, which includes measuring body weight, BMI, and recent weight changes. Laboratory tests play a critical role; these typically involve checking serum electrolytes, renal and liver function, blood glucose levels, and blood counts. These tests help identify existing imbalances or organ dysfunction that could affect TPN administration.

A detailed review of the patient’s medical history is also vital. Conditions such as infections, metabolic disorders, or cardiovascular instability need to be accounted for. Contraindications like inadequate vascular access or a nonfunctioning gastrointestinal system must be identified to determine if TPN is appropriate.

The vascular access site requires careful evaluation. Proper placement of the central venous catheter—usually via the internal jugular, subclavian, or PICC line—is critical for safe infusion. The healthcare team should assess for potential risks like thrombosis or infection at the insertion site.

In addition to physical assessment, patient and caregiver education are foundational. They should be trained in sterile techniques for handling supplies, recognizing signs of complications (such as infection or catheter issues), and performing basic line care.

Planning the TPN formulation involves collaboration among healthcare professionals, including dietitians and pharmacists. Once the patient's specific needs are understood and risks are minimized, a tailored nutrient mixture is prepared, stored properly, and ready for safe administration.

This comprehensive preparation aims to reduce risks, improve tolerance, and ensure that TPN delivers the intended nutritional support effectively.

Formulation Design and Compounding of TPN Solutions

Prepare sterile, personalized TPN formulations with careful compatibility and stability checksThe preparation of Total Parenteral Nutrition (TPN) solutions involves meticulous formulation and sterile compounding processes tailored to individual patient needs. TPN solutions typically comprise three primary macronutrients—dextrose (glucose), amino acids (protein precursors), and lipid emulsions—each providing essential calories and nutrition. Micronutrients such as vitamins, electrolytes, minerals, and trace elements are added to support metabolic functions and correct specific deficiencies.

To formulate a TPN, healthcare professionals calculate the required amounts of each component based on patient-specific parameters like age, weight, clinical condition, and laboratory values. These calculations ensure balanced ratios that meet caloric, protein, and micronutrient needs while avoiding complications like overfeeding or electrolyte imbalances.

During compounding, strict sterile techniques are employed to prevent microbial contamination. The components are dissolved and mixed in a sterile environment, often using automated compounding devices that enhance precision and reduce human error. Compatibility testing is crucial, particularly when combining components into a 3-in-1 admixture, which includes amino acids, dextrose, and lipids in a single bag. Compatibility considerations include preventing phase separation, emulsion breakdown, and interactions that could destabilize the mixture.

Stability and compatibility are assessed by consulting stability data and guidelines from manufacturers and professional organizations. The final mixture must be isotonic to minimize irritation and compatible with the central venous catheter. Adjustments may be needed over time based on ongoing laboratory monitoring such as electrolytes, liver function, and blood glucose levels.

In addition to precise formulation, proper storage—typically refrigerated and brought to room temperature before infusion—is vital to maintain stability. The sterile preparation process involves disinfecting vial tops, using sterile syringes for additive medications or vitamins, and ensuring all equipment is sterile. Once compounded, the TPN solution is labeled correctly with patient details, preparation date, and expiry time, then stored under specified conditions until administration.

This rigorous process in formulation and compounding aims to deliver a safe, effective nutritional therapy that meets individual patient needs while minimizing risks such as infection, instability, or adverse reactions. Regular monitoring during infusion and adjustments ensure ongoing safety and nutritional adequacy.

Monitoring and Managing Potential Complications

What are common complications of TPN and how can they be managed?

Total parenteral nutrition (TPN) is a valuable therapy for patients unable to meet their nutritional needs through oral or enteral routes. However, it carries potential risks and complications that require vigilant monitoring and management.

One of the most significant concerns is infections, especially catheter-related bloodstream infections (CRBSI). Maintaining strict sterile techniques during line insertion and care, along with regular line maintenance—such as dressing changes and flushing with sterile saline—are crucial in prevention. Any signs of redness, swelling, fever, or chills should prompt immediate evaluation.

Metabolic disturbances are also common with TPN. Hyperglycemia occurs if glucose infusion rates exceed the patient’s utilization; thus, blood glucose levels should be checked frequently, and insulin therapy adjusted as needed. Conversely, hypoglycemia can happen if TPN is stopped abruptly without proper tapering or transition, so gradual weaning is recommended.

Electrolyte imbalances, including abnormal sodium, potassium, magnesium, and phosphorus levels, must be closely monitored via laboratory tests. Correcting these imbalances involves adjusting the electrolyte content in the TPN formula and addressing underlying issues such as renal function or ongoing fluid losses.

Liver dysfunction, notably cholestasis and fatty liver, may develop with long-term TPN use. These conditions can be minimized by cycling TPN and avoiding overfeeding, particularly with excess lipids.

Line complications like thrombosis, line occlusion, or pneumothorax require prompt intervention. Ensuring proper line placement, regular assessment of line function, and immediate response to any line troubles are critical. Proper line flushing, adherence to aseptic technique, and routine imaging can help detect issues early.

A comprehensive approach involving a multidisciplinary team ensures early detection and management of these complications. Regular laboratory assessments—including blood glucose, electrolytes, liver enzymes, triglycerides, and markers of nutrient status—help guide therapy adjustments.

In summary, diligent monitoring, adherence to sterile procedures, and individualized management protocols are essential in preventing and controlling TPN-related complications, ultimately improving patient safety and outcomes.

Safety Protocols and Best Practices During TPN Setup and Administration

What safety protocols and best practices should be followed during TPN setup and administration?

Administering Total Parenteral Nutrition (TPN) requires meticulous attention to safety measures to prevent complications such as infections, line issues, and nutrient imbalances. The cornerstone of safe practice is strict aseptic technique. Healthcare providers should thoroughly disinfect their hands and all preparation surfaces before handling TPN components. When preparing the solution, sterilized equipment must be used in a clean environment that is free of dust, pets, and unnecessary traffic.

The preparation process involves checking the TPN bag for correctness, including verifying the label, expiration date, and appearance—look for leaks, cloudiness, or floating particles. Additives like medications or vitamins are added under sterile conditions, with syringes disinfected using alcohol wipes, and ports on the bag are cleaned before injection.

Line care and securement are crucial to prevent dislodgement and infections. The central venous catheter (CVC) insertion site must be regularly inspected for redness, swelling, or signs of infection. Proper catheter securement techniques and dressing changes using sterile dressings help minimize line-related infections. Flushing protocols, usually with sterile saline, maintain line patency and prevent clots or blockages.

Using in-line filters, such as 1.2-micron filters, is recommended to trap particulates and prevent embolic events. It is vital to ensure medication compatibility with the TPN mixture to avoid precipitates and adverse reactions. Filters need regular checks and replacement if occluded or after 24 hours of use.

Proper storage and handling of TPN are essential. The solution should be stored in a refrigerator at around 35°F (1.6°C), checked for leaks, and allowed to warm to room temperature before infusion. During infusion, TPN should be administered with an infusion pump set to the prescribed rate, with continuous monitoring of the patient’s blood glucose, electrolytes, and signs of infection or line complication.

In summary, adherence to aseptic techniques, diligent line care, appropriate filter use, medication compatibility checks, and proper storage are all vital practices that support safe and effective TPN therapy. Regular training, documentation, and awareness of emergency protocols further enhance patient safety during TPN administration.

Procedures and Equipment for TPN Preparation and Administration

What procedures and equipment are involved in the preparation and administration of TPN?

The preparation of Total Parenteral Nutrition (TPN) is a meticulous process carried out by pharmacy staff to ensure safety and efficacy. It begins with calculating the precise caloric and nutrient requirements for the patient, which involves a detailed assessment of clinical needs, often using formulas or indirect calorimetry.

Once calculations are complete, the actual preparation involves sterile compounding techniques. Pharmacy personnel set up a clean, disinfected environment, thoroughly wash hands, and use sterile gloves, equipment, and solutions. They first verify the ingredients, labels, expiration dates, and check for leaks or cloudiness.

The amino acid/dextrose solutions and lipid emulsions are then mixed under strict aseptic conditions. These mixtures are typically prepared in large or small bags, depending on the components added. Any medications, vitamins, or electrolytes are added in a sterile manner, using syringes and following protocols to prevent contamination.

Before administration, these solutions are checked visually for clarity, proper mixing, and absence of particles.

Equipment used during preparation includes sterile syringes, IV filters, and infusion pumps. The TPN solution is stored in a refrigerator at 35°F (1.6°C) and brought to room temperature before use.

For administration, a central venous catheter (CVC)—placed via subclavian, jugular, or PICC line—is employed due to the hyperosmolar nature of TPN. Proper insertion and maintenance of the catheter are critical to prevent infections.

The sterile TPN is connected to the patient through an infusion set attached to the CVC. An infusion pump, often a Curlin pump, regulates the flow rate, which can be continuous or cycled over specific hours.

Monitoring during administration includes checking blood glucose, electrolytes, liver and kidney function, and observing for signs of complications like infection or catheter issues. Proper aseptic technique throughout the process of preparation, connection, and infusion is vital to ensure patient safety and prevent infections.

In summary, TPN preparation and administration require precise calculations, sterile compounding, proper equipment, and vigilant monitoring to deliver nutrients safely and effectively.

Routine Infusion Management of TPN

What is the typical routine for TPN infusion?

The routine for administering Total Parenteral Nutrition (TPN) is meticulous and follows strict sterile procedures to ensure patient safety and treatment efficacy. Initially, preparation involves verifying the correct composition of the TPN solution—checking labels, expiration dates, and infection control essentials such as sterile gloves and disinfected workspaces.

Once prepared, the infusion setup is aseptically connected. This includes attaching the TPN bag to an infusion set and ensuring the connection is secure. Prior to starting the pump, the central venous catheter (CVC) is flushed with sterile saline to clear any residual blood or medication, reducing the risk of clotting or infection.

In a hospital setting, TPN is typically administered continuously over 24 hours using an infusion pump, such as a Curlin pump. The pump is programmed to deliver the appropriate rate according to the patient’s prescribed nutritional needs, which are individualized based on their health status. Careful attention is paid to the initial infusion rate, usually starting at no more than 50% of the target, and then gradually increased (permissive underfeeding) to prevent metabolic complications.

Continuous monitoring during infusion is essential. Healthcare providers check serum electrolytes, blood glucose levels, and vital signs regularly to detect any early signs of metabolic imbalance, such as hyperglycemia or electrolyte disturbances. They also observe the site for signs of infection or catheter-related issues.

For home care, TPN is often administered in a cycling manner, typically over 12 to 16 hours per day, aligning with the patient’s lifestyle and metabolic needs. Patients or caregivers are trained extensively in aseptic techniques, pump operation, and recognizing complications.

Once the infusion is complete, the line must be carefully flushed with sterile saline to maintain catheter patency. Disposal of used supplies follows strict infection control protocols to prevent any contamination.

This routine process underscores the importance of precision, sterile technique, and ongoing assessment to mitigate risks such as infection, metabolic derangements, and catheter complications, ensuring effective nutritional support for the patient.

Educational Points for Proper TPN Management

Managing total parenteral nutrition (TPN) effectively requires thorough education for both healthcare providers and caregivers. Key lessons include proper preparation and aseptic techniques to prevent infections. This involves meticulous hand hygiene, disinfecting vials and ports, and ensuring sterile procedures during mixing and administration.

Training should emphasize the correct handling of equipment such as infusion pumps, central venous catheters, and sterile supplies. Users must learn how to program pumps accurately, troubleshoot common alarms, and perform routine maintenance like flushing lines with saline and heparin.

Monitoring for adverse reactions is crucial. Caregivers and providers should be vigilant for signs of infection, such as redness, swelling at the insertion site, fever, or chills. Recognizing symptoms of metabolic disturbances, like hyperglycemia and electrolyte imbalances, allows prompt intervention.

Proper storage of TPN solutions is essential; bags should be refrigerated, checked for expiration, leaks, and cloudiness before use. When adding medications or vitamins, clinicians should follow sterile protocols, ensuring compatibility and stability.

Signs of complications such as access site infections, metabolic issues, or pump failures necessitate immediate medical attention. Routine blood tests for electrolytes, blood glucose, and organ function guide adjustments in the TPN formula.

Educating patients and caregivers also involves teaching catheter care to prevent infections, proper infusion procedures, and how to safely disconnect and dispose of supplies. This education maximizes safety, minimizes risks, and supports effective nutritional therapy.

Overall, adherence to these educational points ensures a safe, effective TPN process that meets individual patient needs and reduces potential complications.

Key Takeaways for Safe and Effective TPN Initiation

Proper preparation, assessment, sterile technique, and ongoing monitoring are fundamental to the successful initiation and management of TPN. Adhering to safety protocols, customizing formulations, and educating both healthcare providers and patients help minimize risks and enhance outcomes, ultimately supporting the patient’s nutritional and clinical needs effectively.

References

July 29, 2026
Compounded medications are a routine part of modern care, but unlike mass-manufactured drugs, each one is prepared individually, which means the standards behind its preparation carry real weight. For providers who order or refer for compounded therapies, a working understanding of those standards is the clearest way to judge whether a pharmacy is safe to trust. This overview covers the standards that govern sterile compounding and what they mean for the medications your patients receive. Why Standards Matter More in Compounding A commercially manufactured drug is produced under FDA oversight in large, validated batches. A compounded medication is prepared for an individual patient, often in small quantities, sometimes because no commercial equivalent exists. That flexibility is exactly why it's clinically valuable — and why the standards around preparation exist. Without rigorous controls, the same customization that helps patients could introduce contamination or error. Our guide to our sterile compounding pharmacy describes how those controls come together in practice. The Regulatory Landscape Sterile compounding sits within a layered framework: The United States Pharmacopeia (USP) publishes the general chapters, most importantly <797> and <800>, that define how compounded preparations should be made and handled. State boards of pharmacy license and inspect pharmacies, including where they're permitted to ship. Multi-state operations must maintain licensure in each state they serve. Accreditation bodies (ACHC, NABP, PCAB) provide independent verification that a pharmacy meets recognized standards. Together, these create the accountability structure behind every compounded dose. USP <797>: Sterile Preparations USP <797> is the cornerstone standard for compounded sterile preparations. It governs the conditions and practices required to keep a preparation free of contamination, including personnel training and garbing, ISO-classified air quality and engineering controls, environmental monitoring, and beyond-use dating. For any medication infused directly into the body, <797> compliance is the baseline expectation, not a premium feature. USP <800>: Hazardous Drugs USP <800> adds a containment layer for hazardous drugs, protecting personnel, patients, and the environment from unintended exposure. It specifies containment engineering controls, PPE, and validated handling procedures for drugs identified as hazardous. When a preparation is both sterile and hazardous, it must satisfy <797> and <800> together. For the details, see our breakdown of USP <800> requirements . Accreditation: Independent Verification Standards are only meaningful if someone checks that they're being met. Accreditation from ACHC, NABP, and PCAB means a pharmacy has been inspected against national benchmarks by an outside authority. For a provider, accreditation is a shortcut to confidence: it signals that the pharmacy's claims about its processes have been independently validated. The Quality-Control Process Behind the standards is a repeatable process that governs each preparation: Pharmacist review of the prescription for appropriateness, compatibility, and dosing Preparation by trained technicians under aseptic conditions In-process and final verification by a licensed pharmacist Sterility testing or filtration validation where required This chain is what turns a standard on paper into a safe medication in a patient's hands. What This Means When You Order When you refer a patient for a compounded therapy, you're effectively extending your own standard of care into another facility. Knowing that a pharmacy is USP-compliant, accredited, and pharmacist-led lets you refer with confidence that the medication will meet the same expectations you'd hold for anything you administer yourself. If you're weighing options, our guide on how to choose a compounding partner walks through the criteria. The Pharmko Standard Pharmko compounds every TPN, IDPN, and IPN preparation in a USP <797>-compliant, ISO Class 5 cleanroom, under ACHC, NABP, and PCAB accreditation, with a licensed pharmacist reviewing and releasing each formula. For the patients who receive our preparations, many of them managing End Stage Renal Disease (ESRD), that standard is the point. Refer a Patient → · [1 (877) 540-2003]
Physician evaluating a sterile compounding pharmacy partner
July 29, 2026
How to evaluate a sterile compounding pharmacy: accreditation, USP compliance, clinical support, turnaround, and the questions every practice should ask.
Sterile compounding pharmacy technician in PPE under a containment hood
July 29, 2026
A clear guide to USP 800 requirements: hazardous drug handling, containment, PPE, and the facility standards every sterile compounding pharmacy must meet.
Myasthenia Gravis and IVIG: What Patients Need to Know About IV Therapy
July 20, 2026
Learn how IVIG therapy works for myasthenia gravis, when it's used, what to expect during infusions, how home IVIG is coordinated, and how Pharmko supports MG patients and their neurologists.
Dobutamine and Inotrope Therapy at Home
July 17, 2026
Learn how home dobutamine infusion works for advanced heart failure, who qualifies, how continuous inotrope therapy is managed at home, and how Pharmko supports cardiac patients and heart failure teams.
CIDP and Home Infusion: IVIG Treatment, Dosing Schedule, and Long-Term Management
July 16, 2026
Learn how IVIG therapy works for CIDP, what the dosing schedule looks like, how to transition to home infusion, and how Pharmko supports long-term CIDP management across 22+ states.
Compounded IV Medications
July 15, 2026
Most medications that patients receive at a hospital or pharmacy come in standardized, commercially manufactured forms, a 500mg antibiotic vial, a pre-filled syringe, a fixed-concentration IV bag. These products work well for many patients. But a significant portion of patients receiving IV therapy have clinical needs that commercial products cannot meet: a dose the manufacturer doesn't make, a formulation incompatible with the patient's allergy profile, or a combination of nutrients that must be tailored to individual lab values. For these patients, compounded IV medications are not optional, they are clinically necessary. Pharmko's sterile compounding services prepare customized IV medications for patients across 22+ states, with every formulation reviewed by a licensed pharmacist and prepared in a USP <797> compliant cleanroom. What Makes an IV Medication 'Compounded'? A compounded medication is one that is prepared specifically for an individual patient by a licensed pharmacist, rather than manufactured in bulk by a pharmaceutical company. Compounding involves combining, mixing, or altering ingredients, active pharmaceutical ingredients, diluents, preservatives, to create a final preparation that meets the patient's unique prescription requirements. For IV therapy specifically, compounding means preparing a sterile preparation, one that is completely free of viable microorganisms and safe to inject or infuse directly into the bloodstream. This requires specialized facilities, equipment, training, and quality systems that go far beyond what a standard retail pharmacy can provide. Pharmko is exclusively a sterile compounding pharmacy. We do not compound oral medications, topical creams, or non-sterile preparations. Every product we make is intended for intravenous, intraperitoneal, or subcutaneous administration. When Are Compounded IV Medications Necessary? The required dose doesn't exist commercially Pharmaceutical manufacturers produce medications in standardized strengths and volumes based on average patient needs. Pediatric patients, patients with renal or hepatic impairment requiring dose adjustments, or patients whose weight or clinical status falls outside standard ranges may need concentrations or volumes that no commercial product provides. Compounding fills this gap precisely. The patient has an allergy to a commercial formulation's inactive ingredients Commercial IV products often contain preservatives, stabilizers, or diluents, sulfites, benzyl alcohol, certain dyes, that some patients cannot tolerate. A compounding pharmacy can prepare an equivalent formulation without the offending ingredient, allowing the patient to receive the therapy safely. The medication requires individualized nutrient formulation Total parenteral nutrition (TPN) is the clearest example: every TPN formula must be individually compounded because no commercial product can provide the precise combination of amino acids, dextrose, lipids, electrolytes, vitamins, and trace minerals a specific patient needs. The formula changes as the patient's labs, weight, and clinical status change, making standardization impossible. The commercial product is unavailable or in shortage Drug shortages are a persistent reality in the US pharmaceutical supply chain. When a commercially manufactured IV medication becomes unavailable, compounding pharmacies can often prepare an equivalent formulation from available active pharmaceutical ingredients, bridging the gap and maintaining continuity of therapy for patients who cannot wait. The therapy requires a custom delivery format Some IV medications require specific pH, osmolarity, or concentration adjustments for compatibility with a patient's IV access device or concurrent medications. A compounding pharmacist reviews compatibility and prepares formulations that are safe and stable for the specific administration route and equipment the patient is using. How Compounded IV Medications Are Made Step 1: Prescription review Every compounded IV medication begins with a valid prescription from a licensed prescriber. Pharmko's pharmacists review the prescription for clinical appropriateness, dosing accuracy, ingredient compatibility, and stability before compounding begins. Step 2: Ingredient sourcing and verification Active pharmaceutical ingredients for compounding must come from FDA-registered suppliers and meet USP monograph specifications. Each lot is verified for identity, potency, and purity before use. Step 3: Sterile preparation in a controlled environment Preparation occurs in an ISO Class 5 laminar airflow workbench or biological safety cabinet, located within a buffer room that meets ISO Class 7 air quality standards. Pharmacy technicians follow validated, written procedures for each preparation type, using aseptic technique to prevent contamination at every step. Step 4: Pharmacist verification and release A licensed pharmacist performs a final check of every preparation, verifying appearance, volume, labeling, and documentation, before the product is released. High-risk or complex preparations may undergo sterility testing with defined beyond-use dates based on test results. Step 5: Cold-chain delivery Most compounded IV medications require refrigeration. Pharmko uses validated cold-chain packaging and delivery logistics to ensure products arrive within their stability windows and remain temperature-controlled until the patient uses them. Quality Standards That Matter Not all compounding pharmacies operate at the same standard. The relevant quality benchmarks for sterile compounding are: USP <797> compliance, the national standard for sterile compounding environments, personnel, and processes. Our guide on USP <797> and USP <800> explains what compliance means in practice ACHC accreditation, independent third-party verification that Pharmko meets clinical quality standards for home infusion and sterile compounding State pharmacy board licensure, Pharmko is licensed in every state where we serve patients Environmental and personnel monitoring, documented air and surface sampling, personnel gowning competency assessments, and media fill testing at defined intervals For a foundational overview of what sterile compounding is and how it differs from retail pharmacy, see our guide on what is sterile compounding for IV therapy . → Contact Pharmko about compounded IV medications: 1-877-540-2003
home infusion therapy Pennsylvania
July 14, 2026
Pharmko provides home infusion therapy across Pennsylvania, IV antibiotics, IVIG, TPN, biologics, and specialty medications. Licensed, ACHC accredited, and available 24/7 statewide.
Home Infusion Therapy in New Jersey
July 14, 2026
Pharmko provides home infusion therapy across New Jersey, IV antibiotics, IVIG, TPN, IDPN, biologics, and more. Licensed, ACHC accredited, and available 24/7 statewide.
Renal dietitian reviewing albumin labs for a peritoneal dialysis patient
July 10, 2026
When to consider IPN for peritoneal dialysis patients with low albumin: clinical criteria, the stepwise nutrition approach, and the referral process.
Show More